Randox at ECCMID 2019 - 1.77

Location : Amsterdam, Netherlands
  Date : 13th-16th April 2019

Cardiac Risk

Reagents

Randox are at the forefront of developing high quality diagnostic solutions for the cardiology field. We are revolutionising the early detection of cardiovascular disease through our innovations that make a real difference to both the clinician and the patient.

 

  

Small-dense LDL Cholesterol – sLDL

sLDL is a subtype of LDL cholesterol. Smaller particles such as sLDL permeate the inner arterial wall more readily and are more susceptible to oxidation, making sLDL particularly atherogenic. Research has shown individuals with a predominance of sLDL have a three-fold increased risk of suffering from a heart attack, making sLDL measurement extremely valuable.

Key Features:

  • Rapid analysis – results can be produced in as little as ten minutes, facilitation faster patient diagnosis and treatment plan implementation
  • Direct, automated test – the Randox sLDL assay is specifically designed for use on automated analysers making the test more convenient and efficient
  • Liquid ready-to-use reagents – for ease of use and convenience
  • Applications available – with instrument specific settings for a wide range of analysers

 

HDL2/3 Cholesterol – HDL2/3

HDL comprises of several subclass particles, which differ in their sizes, densities and components. These HDL subclasses are considered to play different roles in the progression and regression of arteriosclerosis. It is widely accepted that there is an inverse correlation between HDL3 Cholesterol and CVD risk.

Key Features:

  • Liquid ready-to-use reagents – for convenience and ease-of-use
  • Allows for quantification of HDL2-C – by the subtraction of HDL3-C from total HDL-C
  • A 2 step procedure – based on patented technology from Denka Seiken
  • Measuring range of 4-60mg/dl for the measurement of clinically important results
  • HDL3 controls and HDL3 calibrator available – offering the complete testing package

 

icons3

Homocysteine

Raised levels of homocysteine can be associated with various disease states including cardiovascular disease, diabetes, dementia, osteoporosis and complications during pregnancy, making homocysteine an essential addition to a laboratory’s testing panel.

Key Features:

  • 2-part liquid ready-to-use kit with calibrators included
  • Minimal interference – ensuring accurate and precise results are produced every time
  • Excellent measuring range – 1.74-47.9µmol/l, enabling the Randox assay to detect abnormal levels related to all homocysteine associated disease states

 

icons2

Lipoprotein(a)

Elevated levels of Lipoprotein(a) (Lp(a)) are considered to be both a causal risk factor and independent genetic marker of atherosclerotic disorders. The major challenge with this test is the size variation of apo(a) within Lp(a). Dependent upon the size of apo(a) in the assay calibrator, many assays under or overestimate apo(a) size in the patient sample. The antibody used in the Randox method detects the complete Lp(a) molecule providing the most accurate and consistent results.

Key Features:

  • Liquid ready-to-use reagents
  • Superior methodology – displaying minimal Apo(a) size related bias
  • Five point calibrator available – giving a true reflection of the isoforms present in the population